Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Learn the key differences between US and EU cosmetic regulations and how to export your products from the USA to Europe in full compliance.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
In November 2015, ANSES proposed classifying titanium dioxide as a carcinogen 1B, impacting its use in various industries. Industry and member states have raised concerns, with discussions ongoing for a final decision by June 2017.
ECHA has proposed adding 11 new substances to Annex XIV under the REACH Regulation, inviting public consultation until February 18, 2016. Stakeholders can comment on substance priority, uses, exemptions, and socio-economic impacts before the final recommendation is submitted.
ECHA is enhancing its oversight on animal testing, requiring companies to use it only as a last resort and to propose alternatives. A consultation with stakeholders is underway to implement these measures, aligning with the European Ombudsman's recommendations.
Navigating the complexities of biocidal product marketing requires a reliable provider to streamline regulatory processes, manage costs, and ensure compliance with EU regulations. Key steps include setting specifications, evaluating providers, and leveraging expert support for strategic and cost-effective solutions.
The Biocides Regulation 528/2012 (BPR) brings you to change your approaches from manufacturing to marketing your product. Many parameters must be taken into account and it can be difficult to navigate. EcoMundo gives you the keys to select a provider to help you to comply.
ECHA's report highlights a growing trend in using alternatives to animal testing for chemical toxicity, with increased implementation of read-across and in vitro methods. This aligns with REACH's goals and is notably advancing in Vietnam with government support.
